Wednesday , October 20 2021

Strides Pharma gets EIR for Singapore facility

Strides Pharma Science has received the Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for Singapore facility, there by confirming the successful closure of the inspection which concluded on February 1, 2019.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Please share this news
<div id="taboola-below-article-thumbnails"></div>
<script type="text/javascript">
  window._taboola = window._taboola || [];
  _taboola.push({
    mode: 'thumbnails-a',
    container: 'taboola-below-article-thumbnails',
    placement: 'Below Article Thumbnails',
    target_type: 'mix'
  });
</script>